TNF and depressive symptom measurement: Studies in patient cohorts have demonstrated an association of the inflammatory mediators involved in the pathogenesis of AD and psoriasis, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and IL-6, with depression or anxiety disorders [17,18].